Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
Phase III, Open-Label, Randomized Study of Lazertinib with Subcutaneous Amivantamab Administered via Manual Injection Compared with Intravenous Amivantamab or Subcutaneous Amivantamab Administered via On Body Delivery System in Patients with EGFR-Mutated Advanced or Metastatic Non-Small Cell Lung Cancer After Progression on Osimertinib and Chemotherapy PALOMA-3.
Study Type: Treatment
Phase: III
NCTID: NCT05388669
Principal Investigator:
Jun Zhang
A Phase III, Randomized, Controlled, Global Multicenter Study to Evaluate the Efficacy and Safety of Oral Tinengotinib versus Physician?s Choice in Subjects with Fibroblast Growth Factor Receptor FGFR-altered, Chemotherapy- and FGFR Inhibitor-Refractory/Relapsed Cholangiocarcinoma FIRST-308
A Phase III, Open-Label, Randomized, Parallel Group Study to Evaluate the Efficacy and Safety of Intrapleural Administration of Adenovirus-Delivered Interferon Alpha-2b rAd-IFN in Combination with Celecoxib and Gemcitabine in Patients with Malignant Pleural Mesothelioma
A Phase III Randomized, Double-Blind, Placebo-Controlled, Multi- Regional, International Study of Durvalumab in Combination with Gemcitabine plus Cisplatin versus Placebo in Combination with Gemcitabine plus Cisplatin for Patients with First-Line Advanced Biliary Tract Cancers TOPAZ-1
A Long-term Follow-up Master Protocol for Participants who Received Cell or Gene Therapies in Other AstraZeneca Studies LOCUS
Study Type: Supportive Care
Phase: IV
NCTID: NCT06194461
Principal Investigator:
Raed Al-Rajabi